Your browser doesn't support javascript.
loading
[Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)]. / Indications des mastectomies de réduction de risque en dehors du risque avéré de prédisposition héréditaire : recommandations du Collège national des gynécologues et obstétriciens français (CNGOF).
Mathelin, Carole; Barranger, Emmanuel; Boisserie-Lacroix, Martine; Boutet, Gérard; Brousse, Susie; Chabbert-Buffet, Nathalie; Coutant, Charles; Daraï, Emile; Delpech, Yann; Duraes, Martha; Espié, Marc; Fornecker, Luc; Golfier, François; Grosclaude, Pascale; Hamy, Anne Sophie; Kermarrec, Edith; Lavoué, Vincent; Lodi, Massimo; Luporsi, Élisabeth; Maugard, Christine M; Molière, Sébastien; Seror, Jean-Yves; Taris, Nicolas; Uzan, Catherine; Vaysse, Charlotte; Fritel, Xavier.
Afiliación
  • Mathelin C; CHRU, avenue Molière, 67200 Strasbourg, France; ICANS, 17, rue Albert-Calmette, 67033 Strasbourg cedex, France. Electronic address: c.mathelin@icans.eu.
  • Barranger E; Centre Antoine-Lacassagne, 6, avenue de Valombrose, 06189 Nice, France. Electronic address: emmanuel.barranger@nice.unicancer.fr.
  • Boisserie-Lacroix M; Institut Bergonié, 229, cours de l'Argonne, 33000 Bordeaux, France. Electronic address: m.boisserie-lacroix@bordeaux.unicancer.fr.
  • Boutet G; AGREGA, service de chirurgie gynécologique et médecine de la reproduction, centre Aliénor d'Aquitaine, centre hospitalier universitaire de Bordeaux, groupe hospitalier Pellegrin, place Amélie-Raba-Léon, 33000 Bordeaux, France. Electronic address: gboutetpourgof@yahoo.fr.
  • Brousse S; CHU de Rennes, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 9, France. Electronic address: susie.brousse@gmail.com.
  • Chabbert-Buffet N; Hôpital Tenon, service de gynécologie-obstétrique, 4, rue de la Chine, 75020 Paris, France. Electronic address: ncbpro@gmail.com.
  • Coutant C; Département d'oncologie chirurgicale, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21079 Dijon cedex, France. Electronic address: CCoutant@cgfl.fr.
  • Daraï E; Hôpital Tenon, service de gynécologie-obstétrique, 4, rue de la Chine, 75020 Paris, France. Electronic address: emile.darai@aphp.fr.
  • Delpech Y; Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice, France. Electronic address: yann.delpech@nice.unicancer.fr.
  • Duraes M; CHU de Montpellier, 191, avenue du Doyen-Giraud, 34295 Montpellier cedex, France. Electronic address: m-duraes@chu-montpellier.fr.
  • Espié M; Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: marc.espie@sls.aphp.fr.
  • Fornecker L; Département d'onco-hématologie, ICANS, 17, rue Albert-Calmette, 67033 Strasbourg cedex, France. Electronic address: L.fornecker@icans.eu.
  • Golfier F; Centre hospitalier Lyon Sud, bâtiment 3B, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France. Electronic address: francois.golfier@chu-lyon.fr.
  • Grosclaude P; CERPOP, Inserm, université Toulouse III, 31059 Toulouse, France. Electronic address: pascale.grosclaude@inserm.fr.
  • Hamy AS; Institut Curie, 26, rue d'Ulm, 75248 Paris, France. Electronic address: hamyannesophie@gmail.com.
  • Kermarrec E; Hôpital Tenon, service de radiologie, 4, rue de la Chine, 75020 Paris, France. Electronic address: edithlefrapper@yahoo.fr.
  • Lavoué V; CHU, service de gynécologie, 16, boulevard de Bulgarie, 35200 Rennes, France. Electronic address: Vincent.LAVOUE@chu-rennes.fr.
  • Lodi M; CHRU, avenue Molière, 67200 Strasbourg, France. Electronic address: massimo.lodi@chru-strasbourg.fr.
  • Luporsi É; Oncologie médicale et oncogénétique, CHR Metz-Thionville, hôpital de Mercy, 1, allée du Château, 57085 Metz, France. Electronic address: e.luporsi@chr-metz-thionville.fr.
  • Maugard CM; Service de génétique oncologique clinique, unité de génétique oncologique moléculaire, hôpitaux universitaires de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France. Electronic address: christine.maugard@chru-strasbourg.fr.
  • Molière S; Imagerie du Sein, CHRU, avenue Molière, 67200 Strasbourg, France. Electronic address: sebastien.moliere@chru-strasbourg.fr.
  • Seror JY; 9 ter, boulevard Montparnasse, 75006 Paris, France. Electronic address: seror.jeanyves@gmail.com.
  • Taris N; Oncogénétique, ICANS, 17, rue Albert-Calmette, 67033 Strasbourg, France. Electronic address: n.taris@icans.eu.
  • Uzan C; Hôpital Pitié-Salpetrière, 47, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: catherine.uzan@aphp.fr.
  • Vaysse C; Service de chirurgie oncologique, CHU Toulouse, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse, France. Electronic address: vaysse.charlotte@iuct-oncopole.fr.
  • Fritel X; Centre hospitalo-universitaire de Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France. Electronic address: xavier.fritel@univ-poitiers.fr.
Gynecol Obstet Fertil Senol ; 50(2): 107-120, 2022 Feb.
Article en Fr | MEDLINE | ID: mdl-34920167
ABSTRACT

OBJECTIVE:

To determine the value of performing a risk-reducting mastectomy (RRM) in the absence of a deleterious variant of a breast cancer susceptibility gene, in 4 clinical situations at risk of breast cancer.

DESIGN:

The CNGOF Commission of Senology, composed of 26 experts, developed these recommendations. A policy of declaration and monitoring of links of interest was applied throughout the process of making the recommendations. Similarly, the development of these recommendations did not benefit from any funding from a company marketing a health product. The Commission of Senology adhered to the AGREE II (Advancing guideline development, reporting and evaluation in healthcare) criteria and followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method to assess the quality of the evidence on which the recommendations were based. The potential drawbacks of making recommendations in the presence of poor quality or insufficient evidence were highlighted.

METHODS:

The Commission of Senology considered 8 questions on 4 topics, focusing on histological, familial (no identified genetic abnormality), radiological (of unrecognized cancer), and radiation (history of Hodgkin's disease) risk. For each situation, it was determined whether performing RRM compared with surveillance would decrease the risk of developing breast cancer and/or increase survival.

RESULTS:

The Commission of Senology synthesis and application of the GRADE method resulted in 11 recommendations, 6 with a high level of evidence (GRADE 1±) and 5 with a low level of evidence (GRADE 2±).

CONCLUSION:

There was significant agreement among the Commission of Senology members on recommendations to improve practice for performing or not performing RRM in the clinical setting.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Mama / Mastectomía Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: Fr Revista: Gynecol Obstet Fertil Senol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Mama / Mastectomía Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: Fr Revista: Gynecol Obstet Fertil Senol Año: 2022 Tipo del documento: Article
...